• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期新冠嗅觉功能障碍患者的心理困扰

Psychological Distress in Patients with Long-lasting COVID-19 Olfactory Dysfunction.

作者信息

Louvrier Manon, Saussez Sven, Lechien Jerome R

机构信息

Division of Laryngology and Broncho-esophagology, Department of Otolaryngology-Head Neck Surgery, EpiCURA Hospital, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

Department of Otorhinolaryngology and Head and Neck Surgery, CHU de Bruxelles, CHU Saint-Pierre, School of Medicine, Brussels, Belgium.

出版信息

J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251328960. doi: 10.1177/19160216251328960. Epub 2025 May 3.

DOI:10.1177/19160216251328960
PMID:40317182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049628/
Abstract

ObjectiveThe aim of this study was to investigate the psychological distress associated with long-lasting COVID-19 olfactory dysfunction (OD).MethodsPatients with an OD lasting for more than 6 months were consecutively recruited from the Dour Medical Center (Belgium) from August 2023 to January 2024. The olfaction was investigated with the Olfactory Disorder Questionnaires (ODQ) and the threshold, identification, and discrimination (TDI) testing. General Anxiety Disorder (GAD-7) and Patient Health Questionnaire (PHQ-9) were used to investigate the psychological distress of patients. The olfactory and psychological outcomes of patients were compared with a group of individuals without OD.ResultsA total of 220 patients and 102 asymptomatic individuals completed the evaluations. The mean duration of OD was 31.1 ± 25.1 months. The mean GAD-7 and PHQ-9 scores were significantly higher in OD patients than in asymptomatic individuals ( < 0.008). The OD patient prevalence of mild-to-severe depression (51.2% vs. 44.1%) and mild-to-severe anxiety (39.5% vs. 32.4%) disorders was significantly higher than asymptomatic individuals. Severe anxiety was associated with the presence of anosmia. GAD-7 and PHQ-9 scores were higher in females than in males. The severity of depression (PHQ-9) and anxiety (GAD-7) was significantly associated with the severity of OD (ODQ) and nasal symptoms (SNOT-22).ConclusionThe presence of a long-lasting OD in patients consulting in otolaryngology is associated with psychological distress. While the causality relationship remains unclear, depression and anxiety symptoms must be investigated in this subgroup of patients with long COVID-19.

摘要

目的

本研究旨在调查与长期新冠病毒感染嗅觉功能障碍(OD)相关的心理困扰。

方法

2023年8月至2024年1月,从比利时多尔医学中心连续招募OD持续超过6个月的患者。使用嗅觉障碍问卷(ODQ)以及阈值、识别和辨别(TDI)测试来评估嗅觉。采用广泛性焦虑障碍量表(GAD-7)和患者健康问卷(PHQ-9)来调查患者的心理困扰。将患者的嗅觉和心理结果与一组无OD的个体进行比较。

结果

共有220名患者和102名无症状个体完成了评估。OD的平均持续时间为31.1±25.1个月。OD患者的GAD-7和PHQ-9平均得分显著高于无症状个体(<0.008)。OD患者中轻度至重度抑郁(51.2%对44.1%)和轻度至重度焦虑(39.5%对32.4%)障碍的患病率显著高于无症状个体。严重焦虑与嗅觉丧失有关。女性的GAD-7和PHQ-9得分高于男性。抑郁(PHQ-9)和焦虑(GAD-7)的严重程度与OD(ODQ)和鼻部症状(SNOT-22)的严重程度显著相关。

结论

在耳鼻喉科就诊的患者中,长期存在的OD与心理困扰有关。虽然因果关系尚不清楚,但对于这一长期新冠病毒感染患者亚组,必须调查其抑郁和焦虑症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b2e/12049628/c126e3ad3d13/10.1177_19160216251328960-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b2e/12049628/9c52003aed80/10.1177_19160216251328960-img2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b2e/12049628/c126e3ad3d13/10.1177_19160216251328960-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b2e/12049628/9c52003aed80/10.1177_19160216251328960-img2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b2e/12049628/c126e3ad3d13/10.1177_19160216251328960-fig1.jpg

相似文献

1
Psychological Distress in Patients with Long-lasting COVID-19 Olfactory Dysfunction.长期新冠嗅觉功能障碍患者的心理困扰
J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251328960. doi: 10.1177/19160216251328960. Epub 2025 May 3.
2
Mood, Anxiety and Olfactory Dysfunction in COVID-19: Evidence of Central Nervous System Involvement?新冠病毒感染患者的情绪、焦虑和嗅觉功能障碍:中枢神经系统受累的证据?
Laryngoscope. 2020 Nov;130(11):2520-2525. doi: 10.1002/lary.28964. Epub 2020 Aug 12.
3
Platelet-Rich Plasma for Treating COVID-19-Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study.富血小板血浆治疗新冠病毒相关嗅觉减退、嗅觉减退和嗅觉异常:一项对照纵向研究。
Otolaryngol Head Neck Surg. 2025 Apr;172(4):1450-1458. doi: 10.1002/ohn.1149. Epub 2025 Jan 31.
4
Long-lasting olfactory dysfunction in COVID-19 patients.新冠病毒感染患者的持久嗅觉功能障碍。
Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3485-3492. doi: 10.1007/s00405-021-07153-1. Epub 2021 Nov 10.
5
Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients.根据 COVID-19 严重程度的流行病学、耳鼻喉科、嗅觉和味觉结果:一项 2579 例患者的研究。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2851-2859. doi: 10.1007/s00405-020-06548-w. Epub 2021 Jan 16.
6
Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.新冠病毒感染患者的嗅觉功能障碍和鼻-鼻窦症状:流行率、严重程度、出现时间和相关特征。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120. doi: 10.1177/0194599820929185. Epub 2020 May 19.
7
Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.富血小板血浆注射治疗 COVID-19 长期嗅觉功能障碍患者的嗅裂。
Eur Arch Otorhinolaryngol. 2023 May;280(5):2351-2358. doi: 10.1007/s00405-022-07788-8. Epub 2022 Dec 15.
8
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.288 例新冠病毒病嗅觉障碍患者的临床系列中嗅觉恢复的预测因素。
Eur J Neurol. 2021 Nov;28(11):3702-3711. doi: 10.1111/ene.14994. Epub 2021 Jul 9.
9
Factors Associated With Persisting Olfactory Dysfunction After COVID-19.新冠病毒感染后持续性嗅觉功能障碍的相关因素
Clin Otolaryngol. 2025 Jan;50(1):53-61. doi: 10.1111/coa.14233. Epub 2024 Sep 21.
10
Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report.D614(野生)和 B.1.1.7. Alpha 变异株感染患者 COVID-19 嗅觉障碍的患病率和演变比较:简短报告。
Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3461-3467. doi: 10.1007/s00405-023-07923-z. Epub 2023 Mar 21.

本文引用的文献

1
Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data.2022年墨西哥成年人中新冠病毒感染后急性后遗症(长新冠)的患病率及其决定因素:一项基于全国代表性数据的回顾性分析
Lancet Reg Health Am. 2024 Feb 3;30:100688. doi: 10.1016/j.lana.2024.100688. eCollection 2024 Feb.
2
Personalized medicine in olfactory testing: perspectives to improve patient compliance to psychophysical tests.嗅觉测试中的个性化医疗:提高患者对心理物理学测试依从性的前景
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):2175-2177. doi: 10.1007/s00405-024-08454-x. Epub 2024 Jan 25.
3
Postinfectious conditions challenge disease-specificity of SNOT-22.
感染后状况对 SNOT-22 的疾病特异性提出挑战。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2395-2402. doi: 10.1007/s00405-023-08385-z. Epub 2024 Jan 4.
4
Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study.比利时新冠疫苗接种中的社会人口学和社会经济差异:一项全国性记录关联研究。
J Epidemiol Community Health. 2023 Dec 26;78(3):176-83. doi: 10.1136/jech-2023-220751.
5
Mood Impairment in Patients with Olfactory Loss Predicts a More Pronounced Recovery of Olfactory Function.嗅觉丧失患者的情绪障碍预示着嗅觉功能的恢复更为明显。
ORL J Otorhinolaryngol Relat Spec. 2024;86(1):13-15. doi: 10.1159/000533629. Epub 2023 Oct 16.
6
Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms.新型冠状病毒肺炎相关嗅觉功能障碍的评估及其与心理、神经精神和认知症状的关联。
Front Neurosci. 2023 Aug 4;17:1165329. doi: 10.3389/fnins.2023.1165329. eCollection 2023.
7
Olfactory Dysfunction and Depression Trajectories in Community-Dwelling Older Adults.社区居住老年人嗅觉功能障碍与抑郁轨迹。
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad139.
8
Persistent olfactory dysfunction associated with poor sleep quality and anxiety in patients with long COVID.长期新冠患者中持续存在的嗅觉功能障碍与睡眠质量差和焦虑相关。
Front Neurosci. 2023 May 12;17:1161904. doi: 10.3389/fnins.2023.1161904. eCollection 2023.
9
Canadian multidisciplinary expert consensus on the use of biologics in upper airways: a Delphi study.加拿大多学科专家共识:生物制剂在上呼吸道疾病中的应用:德尔菲研究。
J Otolaryngol Head Neck Surg. 2023 Apr 24;52(1):30. doi: 10.1186/s40463-023-00626-9.
10
Association of preexisting psychiatric disorders with post-COVID-19 prevalence: a cross-sectional study.与新冠病毒后流行相关的先前存在的精神障碍的关联:一项横断面研究。
Sci Rep. 2023 Jan 7;13(1):346. doi: 10.1038/s41598-023-27405-w.